Literature DB >> 28325171

Pregnancy and neonatal outcomes among a cohort of HIV-infected women in a large Italian teaching hospital: a 30-year retrospective study.

S Grignolo1, R Agnello2, D Gerbaldo2, C Gotta3, C Alicino4, F Del Puente1, L Taramasso1, B Bruzzone5, C Gustavino2, S Trasino3, A DE Maria1, G Icardi4, C Viscoli1, A DI Biagio1.   

Abstract

The primary study objective was to investigate three decades from 1985 to 2014 of changes in pregnancies among HIV-infected women. The secondary objective was to assess risk factors associated with preterm delivery and severe small-for-gestational-age (SGA) infants in HIV-infected women. A retrospective review of deliveries among pregnant HIV-infected women at the University of Genoa and IRCCS San Martino-IST in Genoa between 1985 and 2014 was performed. Univariate and multivariable analyses were used to study the variables associated with neonatal outcomes. Overall, 262 deliveries were included in the study. An increase in median age (26 years in 1985-1994 vs. 34 years in 2005-2014), in the proportion of foreigners (none in 1985-1994 vs. 27/70 (38·6%) in 2005-2014), and a decrease in intravenous drug use (75·2% (91/121) in 1985-1994 vs. 12·9% (9/70) in 2005-2014) among pregnant HIV-infected women was observed. Progressively, HIV infections were diagnosed sooner (prior to pregnancy in 80% (56/70) of women in the last decade). An increase in combined antiretroviral therapy (cART) prescription during pregnancy (50% (27/54) in 1995-2004 vs. 92·2% (59/64) in 2005-2014) and in HIV-RNA <50 copies/ml at delivery (19·2% (5/26) in 1995-2004 vs. 82·3% (53/64) in 2005-2014) was observed. The rate of elective caesarean section from 1985 to 1994 was 9·1%, which increased to 92·3% from 2004 to 2015. Twelve (10·1%) mother-to-child transmissions (MTCT) occurred in the first decade, and six (8·3%) cases occurred in the second decade, the last of which was in 2000. Preterm delivery (<37 weeks gestation) was 5% (6/121) from 1985 to 1994 and increased to 17·1% (12/70) from 2005 to 2014. In univariate and multivariable logistic regression analyses, advancing maternal age and previous pregnancies were associated with preterm delivery (odds ratio (OR) 2·7; 95% confidence intervals (CI) 1-7·8 and OR 2·6; 95% CI 1·1-6·7, respectively). In the logistic regression analysis, use of heroin or methadone was found to be the only risk factor for severe SGA (OR 3·1; 95% CI 1·4-6·8). In conclusion, significant changes in demographic, clinical and therapeutic characteristics of HIV-infected pregnant women have occurred over the last 30 years. Since 2000, MTCT has decreased to zero. An increased risk of preterm delivery was found to be associated with advancing maternal age and previous pregnancies but not with cART. The use of heroin or methadone has been confirmed as a risk factor associated with severe SGA.

Entities:  

Keywords:  HIV; mother-to-child transmission; pregnancy; preterm delivery; small for gestational age

Mesh:

Year:  2017        PMID: 28325171      PMCID: PMC9203286          DOI: 10.1017/S095026881700053X

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  31 in total

1.  Is antiretroviral therapy during pregnancy associated with an increased risk of preterm delivery, low birth weight, or stillbirth?

Authors:  Amanda M Cotter; Adolfo Gonzalez Garcia; M Lunthita Duthely; Barbara Luke; Mary J O'Sullivan
Journal:  J Infect Dis       Date:  2006-03-28       Impact factor: 5.226

2.  Optimizing the definition of intrauterine growth restriction: the multicenter prospective PORTO Study.

Authors:  Julia Unterscheider; Sean Daly; Michael Patrick Geary; Mairead Mary Kennelly; Fionnuala Mary McAuliffe; Keelin O'Donoghue; Alyson Hunter; John Joseph Morrison; Gerard Burke; Patrick Dicker; Elizabeth Catherine Tully; Fergal Desmond Malone
Journal:  Am J Obstet Gynecol       Date:  2013-04       Impact factor: 8.661

3.  HIV-infected pregnant women and vertical transmission in Europe since 1986. European collaborative study.

Authors: 
Journal:  AIDS       Date:  2001-04-13       Impact factor: 4.177

4.  Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention.

Authors:  Mary G Fowler; Min Qin; Susan A Fiscus; Judith S Currier; Patricia M Flynn; Tsungai Chipato; James McIntyre; Devasena Gnanashanmugam; George K Siberry; Anne S Coletti; Taha E Taha; Karin L Klingman; Francis E Martinson; Maxensia Owor; Avy Violari; Dhayendre Moodley; Gerhard B Theron; Ramesh Bhosale; Raziya Bobat; Benjamin H Chi; Renate Strehlau; Pendo Mlay; Amy J Loftis; Renee Browning; Terence Fenton; Lynette Purdue; Michael Basar; David E Shapiro; Lynne M Mofenson
Journal:  N Engl J Med       Date:  2016-11-03       Impact factor: 91.245

Review 5.  Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis.

Authors:  Athena P Kourtis; Christopher H Schmid; Denise J Jamieson; Joseph Lau
Journal:  AIDS       Date:  2007-03-12       Impact factor: 4.177

6.  Earlier initiation of ART and further decline in mother-to-child HIV transmission rates, 2000-2011.

Authors:  Claire L Townsend; Laura Byrne; Mario Cortina-Borja; Claire Thorne; Annemiek de Ruiter; Hermione Lyall; Graham P Taylor; Catherine S Peckham; Pat A Tookey
Journal:  AIDS       Date:  2014-04-24       Impact factor: 4.177

7.  Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000-2006.

Authors:  Claire L Townsend; Mario Cortina-Borja; Catherine S Peckham; Annemiek de Ruiter; Hermione Lyall; Pat A Tookey
Journal:  AIDS       Date:  2008-05-11       Impact factor: 4.177

8.  Antiretroviral therapies in pregnancy: maternal, fetal and neonatal effects. Swiss HIV Cohort Study, the Swiss Collaborative HIV and Pregnancy Study, and the Swiss Neonatal HIV Study.

Authors:  P Lorenzi; V M Spicher; B Laubereau; B Hirschel; C Kind; C Rudin; O Irion; L Kaiser
Journal:  AIDS       Date:  1998-12-24       Impact factor: 4.177

9.  Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.

Authors:  E M Connor; R S Sperling; R Gelber; P Kiselev; G Scott; M J O'Sullivan; R VanDyke; M Bey; W Shearer; R L Jacobson
Journal:  N Engl J Med       Date:  1994-11-03       Impact factor: 91.245

10.  Antiretroviral therapy during pregnancy and the risk of an adverse outcome.

Authors:  Ruth E Tuomala; David E Shapiro; Lynne M Mofenson; Yvonne Bryson; Mary Culnane; Michael D Hughes; M J O'Sullivan; Gwendolyn Scott; Alice M Stek; Diane Wara; Marc Bulterys
Journal:  N Engl J Med       Date:  2002-06-13       Impact factor: 91.245

View more
  1 in total

1.  Viremia copy-years and risk of estimated glomerular filtration rate reduction in adults living with perinatal HIV infection.

Authors:  Giovanni Sarteschi; Antonio Di Biagio; Emanuele Focà; Lucia Taramasso; Francesca Bovis; Anna Celotti; Michele Mirabella; Laura Magnasco; Sara Mora; Mauro Giacomini; Matteo Bassetti
Journal:  PLoS One       Date:  2020-10-15       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.